| |
| |
|
| Insider
Information: |
Perry Michael S |
| Relationship: |
Director |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
273,904 |
|
|
Indirect Shares
|
411,105 |
|
|
| Direct
Value |
$2,842,531 |
|
|
|
Indirect Value
|
$130,690 |
|
|
| Total
Shares |
685,009 |
|
|
| Total
Value |
$2,973,221 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 105.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xeno Transplants Corp |
XENO |
Director |
2007-05-03 |
150,000 |
|
0 |
Premium* |
|
|
Armata Pharmaceuticals, Inc |
ARMP |
Director |
2018-03-22 |
230 |
2018-03-22 |
411,105 |
Premium* |
|
|
Poniard Pharmaceuticals |
PARD |
President & CMO |
2012-03-27 |
8,920 |
2010-04-20 |
0 |
Premium* |
|
|
Arrowhead Pharmaceuticals Inc |
ARWR |
Director |
2023-12-15 |
114,754 |
2014-02-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2023-12-15 |
4 |
A |
$25.41 |
$380,820 |
D/D |
14,987 |
114,754 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2023-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,867 |
99,767 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,400 |
91,900 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2022-01-03 |
4 |
AS |
$64.30 |
$291,192 |
D/D |
(4,500) |
85,500 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2021-01-04 |
4 |
S |
$76.09 |
$304,360 |
D/D |
(4,000) |
90,000 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2021-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
94,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2020-05-14 |
4 |
OE |
$2.01 |
$285,200 |
D/D |
77,000 |
85,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2020-05-12 |
4 |
S |
$35.71 |
$1,289,891 |
D/D |
(36,000) |
8,000 |
0 |
% |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2020-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
44,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2019-09-11 |
4 |
S |
$30.00 |
$2,550,000 |
D/D |
(85,000) |
36,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2019-09-09 |
4 |
S |
$28.90 |
$2,890,000 |
D/D |
(100,000) |
121,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2019-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
221,000 |
0 |
- |
|
| ARMP |
Armata Pharmaceuticals, I... |
Director |
– • – |
2018-03-22 |
4 |
B |
$1.10 |
$200,002 |
I/I |
181,820 |
411,105 |
2.1 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2018-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
185,000 |
0 |
- |
|
| ARMP |
Armata Pharmaceuticals, I... |
Director |
– • – |
2017-09-19 |
4 |
B |
$0.00 |
$0 |
I/I |
105,015 |
229,285 |
2.02 |
- |
|
| ARMP |
Armata Pharmaceuticals, I... |
Director |
– • – |
2017-06-29 |
4 |
B |
$0.00 |
$0 |
I/I |
5,757 |
124,270 |
2.02 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2017-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
155,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2016-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
75,000 |
0 |
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2015-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
45,000 |
0 |
- |
|
| ARMP |
Armata Pharmaceuticals, I... |
Director |
– • – |
2014-02-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
45,000 |
|
- |
|
| ARWR |
Arrowhead Pharmaceuticals... |
Director |
– • – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
President & CMO |
• – – |
2012-03-27 |
4 |
S |
$0.83 |
$1,330 |
D/D |
(1,599) |
8,920 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
President & CMO |
• – – |
2012-03-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,800 |
10,519 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
President & CMO |
• – – |
2012-02-16 |
4 |
S |
$0.87 |
$5,508 |
D/D |
(6,346) |
7,719 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
President & CMO |
• – – |
2012-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,019 |
14,065 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
